PlainPharmaWatch

CMS Open Payments · Tool

Novavax Inc vs Chiesi USA, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Novavax Inc has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 4,878, versus 1,223 for the other company. Its single largest recorded recipient represents 0.7% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Novavax Inc
HHI 4,878 · top recipient 0.7%
Ranked #380 of 1,838 companies by HHI
Chiesi USA, Inc.
HHI 1,223 · top recipient 0.3%
Ranked #938 of 1,838 companies by HHI

Payment Overview

Company A

Novavax Inc

Total Payments
$30.4M
% of Industry
0.2%
Transactions
2,290
Avg per Transaction
$13.3K
Recipients
104
Avg per Recipient
$292.1K
Payment Types
4
Top Payment Type
Consulting Fee
Company B

Chiesi USA, Inc.

Total Payments
$30.8M
% of Industry
0.2%
Transactions
16,480
Avg per Transaction
$1.9K
Recipients
9,915
Avg per Recipient
$3.1K
Payment Types
10
Top Payment Type
Royalty or License

Highlighted values indicate the higher figure for each metric.

Total payments compared

Novavax Inc vs Chiesi USA, Inc. - total reported payments in CMS Open Payments PY2024

Chiesi USA, Inc.$30.8MNovavax Inc$30.4M

Payment Types Breakdown

Novavax Inc

Consulting Fee $131.8K

0.4%

Compensation for Services Other Than Consulting $7.0K

0.0%

Travel and Lodging $5.3K

0.0%

Food and Beverage $2.8K

0.0%

Chiesi USA, Inc.

Royalty or License $1.7M

5.7%

Grant $1.3M

4.3%

Consulting Fee $983.1K

3.2%

Honoraria $447.3K

1.5%

Compensation for Services Other Than Consulting $338.1K

1.1%

Food and Beverage $264.5K

0.9%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Novavax Inc

  1. 1

    PHILIP KRAUSE

    $101,333.34 · 5 txns

  2. 2

    ROBERT ENELOW

    $9,150.00 · 3 txns

  3. 3

    TRACEY PIPARO

    $6,921.95 · 15 txns

  4. 4

    ZAIFANG YU

    $6,900.00 · 3 txns

  5. 5

    LETHA JOSEPH

    $5,944.06 · 17 txns

Chiesi USA, Inc.

  1. 1

    HOSPITAL OF THE UNIV OF PENNA

    $1,745,951.93 · 4 txns

  2. 2

    UNIV OF MI HOSPITALS & HLTH CTRS

    $412,580.00 · 6 txns

  3. 3

    EMORY UNIVERSITY HOSPITAL

    $368,012.00 · 1 txns

  4. 4

    WASHINGTON HOSPITAL CENTER

    $285,000.00 · 4 txns

  5. 5

    MARIANNE MANN

    $184,080.00 · 11 txns

Summary Comparison

Metric Novavax Inc Chiesi USA, Inc.
Total Payments $30.4M $30.8M
% of Industry Total 0.2% 0.2%
Transaction Count 2,290 16,480
Avg per Transaction $13.3K $1.9K
Recipient Count 104 9,915
Avg per Recipient $292.1K $3.1K
Payment Type Count 4 10
Top Payment Type Consulting Fee Royalty or License

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.